You are here

Bioiberica highlights science, sustainability, and strategic partnerships at CPHI 2023

16 Oct 2023
Bioiberica

We participated in CPHI 2023 in Barcelona, ​​where we showcased our leadership in scientific research, sustainable development and strategic partnerships for a more resilient future with our portfolio of Active Pharmaceutical and Nutraceutical Ingredients.

Alongside its market-leading API portfolio, the company will present the latest research for its mobility, digestive and skin health branded ingredients. Attendees will also have the opportunity to explore Bioiberica’s newfound focus on advanced wound care – a captivating area of research in the medical nutrition arena, as well as find out more about the company's sustainability goals following the publication of its 2023 climate strategy report.

 

Ingredient science takes centre stage  

Bioiberica will exhibit its essential APIs – chondroitin sulfate and glucosamine for the symptomatic treatment of osteoarthritis, thyroid for endocrinology and its flagship ingredient, Heparin. For the first time, it will spotlight its expertise in wound care too; sharing the scientific data set to unlock a new world of co-innovation possibilities. On stand, the company will also present the latest research supporting the efficacy of its branded ingredients – Collavant n2 (native (undenatured) type II collagen), Mobilee® (hyaluronic acid matrix ingredient) for joint health and mobility, Dermial® (hyaluronic acid matrix ingredient) for skin health and DAOgest (diamine oxidase enzyme) for histamine intolerance.

 

Shining a spotlight on sustainability

With sustainability top of the agenda for the pharmaceutical industry, Bioiberica will illuminate the transformative potential of its latest sustainability initiatives and how they’re helping to enhance its customers’ green credentials in the face of mounting pressures. Attendees can connect with Bioiberica’s experts on booth 7P20 to learn more about its circular bioeconomy model, targets to obtain 100% renewable electricity by 2024 and 30% less GHG emissions by 2030, and ambitious plans to achieve climate neutrality by 2050.

 

Fusing science, sustainability and strategic partnerships

“CPHI is always a fantastic opportunity to connect with customers – new and old – but the excitement has been taken up a notch this year as we welcome key stakeholders from across the global pharmaceutical landscape to our hometown, Barcelona,” comments Luis Solera, CEO at Bioiberica. “Progression in the healthcare space hinges on three key pillars: science, sustainability and strategic partnership. CPHI 2023 offers us a platform to highlight the substantial strides we’ve made to strengthen these foundations and showcase how we’re supporting our customers in addressing some of the most pressing challenges facing the pharmaceutical industry. Visitors are warmly invited to our booth where we look forward to fostering innovative ideas together!”

Meet Bioiberica at CPHI 2023 on stand 7P20 to learn more about the company's APIs and branded ingredients for human health. For more information visit here.

Related News

23 Jan 2024
Bioiberica

On a planet where natural resources are limited and there is increasing concern for the environment, the circular economy has emerged as an innovative and sustainable solution.

4 May 2023
Bioiberica

They've set up Biovall Heparin Science, a joint pharmaceutical innovation project with an investment of 25 million euros and 20 skilled jobs

28 Apr 2023
Bioiberica

Join Bioiberica at stand F130 in Geneva, 9-11 May to discover the company’s latest science and insights driving innovation in the nutraceuticals market.

Bioiberica